Schizophrenia Mental and Behavioural Disorders
Conditions
Interventions
Current interventions as of 02/12/2025:
Patients with mental disorders were randomly allocated to the experimental group and the control group. The control group received routine treatment, whereas
Sponsors
Renmin Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with schizophrenia diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria 2. Age between 18 and 65 years 3. Commitment to comply with the study procedures and cooperate with the implementation of the entire research process
Exclusion criteria
Exclusion criteria: 1. Severe neurological diseases or traumatic brain injury 2. Substance dependence 3. Administration of nonsteroidal or steroidal anti-inflammatory drugs within 2 weeks 4. Having a history of severe allergies, currently suffering from skin diseases or immune system diseases 5. Pregnancy Added 19/01/2026: 6. Allergic to adhesive tape
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychotic symptoms measured using the Positive and Negative Syndrome Scale were measured at baseline and month 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| Current key secondary outcome(s) as of 02/12/2025: 1. Niacin skin flushing response were measured at baseline and month 3 _____ Previous key secondary outcome(s): 1. Niacin skin flushing response were measured at baseline and month 3 2. Cognition measured using the Brief Assessment of Cognition in Schizophrenia were measured at baseline and month 3 | — |
Countries
China
Contacts
Public ContactShijing Wang
Outcome results
None listed